| RS1743380522 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS1743386760 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1743394245 |
NIPBL
|
Health Risk |
Likely pathogenic |
Vesicoureteral reflux, Mild intellectual disability |
| RS1743537160 |
RETREG1
|
Health Risk |
Pathogenic |
— |
| RS1743560254 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1743583345 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1743611889 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1743668356 |
OXCT1
|
Health Risk |
Likely pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS1743680168 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1743709062 |
LMBRD2
|
Health Risk |
Likely pathogenic |
brain structure abnormalities, Developmental delay |
| RS1743846367 |
PROM1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1743896594 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS1743983240 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS1744033286 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744037495 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1744038356 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1744118616 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1744128996 |
GFM2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation deficiency 39, Combined oxidative phosphorylation deficiency 39 |
| RS1744149615 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1744152835 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS1744154190 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1744154635 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744167818 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744168201 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS1744169857 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744257909 |
LIFR
|
Health Risk |
Likely pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS1744285692 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1744286516 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1744286598 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744287132 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744295671 |
PIK3R1
|
Health Risk |
Pathogenic |
— |
| RS1744302993 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1744309029 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1744312712 |
NEK1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis, susceptibility to |
| RS1744320103 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1744356274 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Familial adenomatous polyposis 4 |
| RS1744356530 |
MSH3
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1744357992 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1744436254 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1744464153 |
PRDM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Brittle cornea syndrome 2, Brittle cornea syndrome 2 |
| RS1744470051 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1744509983 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1744531551 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744532481 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1744532526 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1744583469 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS1744629354 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744630430 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1744639200 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1744650400 |
FAT1
|
Health Risk |
Pathogenic |
— |
| RS1744666930 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia 3 |
| RS1744682329 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1744695193 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1744699899 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1744706299 |
LIAS
|
Health Risk |
Pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1744708369 |
LIAS
|
Health Risk |
Pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1744715983 |
LIAS
|
Health Risk |
Likely pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1744806313 |
LIAS
|
Health Risk |
Likely pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1744807781 |
LIAS
|
Health Risk |
Pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1744812773 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1744829646 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1744838539 |
FAT1
|
Health Risk |
Pathogenic |
— |
| RS1744878590 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1744987309 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1744988064 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745048937 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1745050969 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1745058899 |
LIAS
|
Health Risk |
Likely pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1745065951 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1745202896 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1745248753 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS17452588 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Tibial muscular dystrophy |
| RS1745281144 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1745312195 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1745312538 |
ADGRV1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1745315730 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1745344357 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1745348853 |
MCIDAS
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745349301 |
MCIDAS
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745349463 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1745368018 |
TRIO
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 63 |
| RS1745369142 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 63 |
| RS1745476784 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1745528455 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS1745570250 |
CCNO
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia 29 |
| RS1745582317 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1745583820 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745585444 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1745611424 |
CCNO
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745647423 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745671912 |
HCN1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 24 |
| RS1745712448 |
SLC6A19
|
Health Risk |
Pathogenic |
— |
| RS1745753552 |
LIFR
|
Health Risk |
Pathogenic |
Stuve-Wiedemann syndrome, Stüve-Wiedemann syndrome 1 |
| RS1745754747 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1745823859 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS1745878088 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS1745879944 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1745881166 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1745928643 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1745933925 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |